Medical News

RSS

Misonix signs new distribution agreement with Varlix Mexico

Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year distribution agreement with Varlix Mexico, S.A. de C.V., based in Mexico City, Mexico, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator and the BoneScalpel(TM) Ultrasonic Bone Cutter. The agreement provides Varlix with the rights to sell exclusively in Mexico and includes minimum purchase requirements.

8 Jan 2010

Nelson's Medicaid deal comes under attack

A special deal reached by Senate Democratic leaders and Sen. Ben Nelson, D-Neb., regarding funding for his state in the context of health reform's proposed Medicaid expansion, is drawing increasing criticism.

8 Jan 2010

LSUHSC receives $2.1 million grant for pneumonia research

Dr. Jay Kolls, Professor and Chairman of Genetics at the LSU Health Sciences Center New Orleans School of Medicine, has been awarded a $2.1 million grant over five years by the National Heart, Lung, and Blood Institute of the National Institutes of Health to further his work on a discovery that plays a critical role in the body's defense against pneumonia.

8 Jan 2010

Initiation of double blind placebo controlled multi-center trial of DAS181 announced

NexBio, Inc. announced today the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection.

8 Jan 2010

Behavioral Innovations partners with insurance companies to mitigate financial burden on parents

Behavioral Innovations, the premier Dallas/Fort Worth provider of Applied Behavior Analysis (ABA) services for families of children with autism and other developmental disorders, announces its partnership with key insurance carriers to offer in-network insurance coverage for several ABA therapy programs. Behavioral Innovations is the first behavioral therapy center in the Metroplex to offer in-network insurance for select treatments - mitigating the financial burden on parents.

8 Jan 2010

Pfizer and Debiopharm Group enter into co-development agreement to conduct Phase 3 trial of tremelimumab

Pfizer Inc. (Pfizer) and Debiopharm Group™ (Debiopharm) announced today that they have entered into a co-development agreement to conduct a Phase 3 trial of tremelimumab (CP675,206), a fully human anti-CTLA4 monoclonal antibody for the treatment of patients with unresectable, Stage IV melanoma.

8 Jan 2010

Difficult to decipher: Tracking the funding sources for some health care interest groups

"Many of the Washington interest groups that are seeking to shape final health-care legislation in the coming weeks operate with opaque financing, often receiving hidden support from insurers, drugmakers or unions," The Washington Post reports.

8 Jan 2010

Kyowa Hakko Kirin receives exclusive rights to develop and commercialize bardoxolone methyl

Reata Pharmaceuticals, Inc. (Reata) and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin) announced today that they have entered into a licensing agreement that provides Kyowa Hakko Kirin with the exclusive rights to develop and commercialize Reata’s lead compound, bardoxolone methyl (bardoxolone), in Japan and other selected Asian markets.

8 Jan 2010

Medtronic invests in GI Dynamics to advance treatment for metabolic disorders

GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that it has received a strategic investment from Medtronic, Inc., the global leader in medical device technology and therapies designed to treat chronic diseases.

8 Jan 2010

Springer signs agreement with ISOBM to co-publish the journal Tumor Biology

Springer, a leading publisher in the fields of science, technology and medicine, has signed an agreement with the International Society of Oncology and BioMarkers (ISOBM) to co-publish the journal Tumor Biology starting in January 2010.

8 Jan 2010

HHS releases nation’s first comprehensive strategy to address existing and emerging health threats

HHS Secretary Kathleen Sebelius today released The National Health Security Strategy, the nation’s first comprehensive strategy focused on protecting people’s health during a large-scale emergency. The strategy sets priorities for government and non-government activities over the next four years.

8 Jan 2010

Senate retirements focus Democrats on election prospects and health bill impact

USA Today reports on the ripple effect of this week's retirement announcements by Sen. Chris Dodd, D-Conn., and Sen. Byron Dorgan, D-N.D.: The "[t]wo Senate retirements have focused Democrats like a laser on their growing November election challenges, but a more pressing contest is less than two weeks away in an unlikely place: Massachusetts." Democrats are favored to retain the seat of the late Sen. Edward M. Kennedy, but Republicans "have increasingly touted the Jan. 19 special election as an opportunity for an upset."

8 Jan 2010

Biovest International receives Orphan Drug Designation for its personalized lymphoma vaccine

Biovest International, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BiovaxID®, Biovest’s personalized lymphoma vaccine. BiovaxID represents a new class of active immunotherapy and is one of the few select late-stage patient-specific cancer vaccines vying to be among the first to reach market.

8 Jan 2010

UCLA: Metformin can be used to treat patients with diabetes and advanced heart failure

A new study has shown that metformin, a drug often used in the treatment of diabetes mellitus, is safe for use in treating patients who have both diabetes and advanced heart failure.

7 Jan 2010

Epigenetic diagnosis and therapies, a new strategy for treating cancer

A tumor's genetic profile is often useful when diagnosing and deciding on treatment for certain cancers, but inexplicably, genetically similar leukemias in different patients do not always respond well to the same therapy.

7 Jan 2010

Opinions: Uganda anti-gay bill; Clinton's foreign policy speech; PEPFAR

A Washington Post editorial calles anti-gay legislation currently under consideration in Uganda "an atrocity." The authors of the editorial write that under the legislation, "anyone convicted of 'aggravated homosexuality,' which could mean someone who is HIV-positive and is intimate with another person of the same sex, could 'suffer death.'"

7 Jan 2010

Nightingale Informatix and CPA sign license and distribution agreement

Nightingale Informatix Corporation ("Nightingale" or the "Company"), an application service provider (ASP) of electronic medical record (EMR) software and related services, announced today that it has entered into an exclusive licensing agreement with Canadian Patient Access Incorporated ("CPA") to offer health related services to Canadian patients, through doctors using electronic medical records in their practices.

7 Jan 2010

Uninsured patients struggle to access health care as hospitals end programs

Several news outlets report on uninsured patients and access to health care.

7 Jan 2010

Additional birth weight decreases risk of developing tuberculosis later in life

Researchers at the University of Michigan looked at how much protection additional birth weight added against developing the disease years later. They found that every 1.1 pounds of birth weight decreases the risk of developing tuberculosis later by 46 percent among identical twins.

7 Jan 2010

CRF awards $1.75 million in 11 new grants to researchers to find a cure for cystinosis

The Cystinosis Research Foundation of Irvine, Calif., announced it awarded $1.75 million in 11 new grants to researchers in the United States, Canada, Belgium and Italy who are working to find a cure for cystinosis, a rare, deadly metabolic and genetic disease that afflicts about 500 children and young adults in the U.S. and 2,000 worldwide.

7 Jan 2010

Medical News

Misonix signs new distribution agreement with Varlix Mexico

Nelson's Medicaid deal comes under attack

LSUHSC receives $2.1 million grant for pneumonia research

Initiation of double blind placebo controlled multi-center trial of DAS181 announced

Behavioral Innovations partners with insurance companies to mitigate financial burden on parents

Pfizer and Debiopharm Group enter into co-development agreement to conduct Phase 3 trial of tremelimumab

Difficult to decipher: Tracking the funding sources for some health care interest groups

Kyowa Hakko Kirin receives exclusive rights to develop and commercialize bardoxolone methyl

Medtronic invests in GI Dynamics to advance treatment for metabolic disorders

Springer signs agreement with ISOBM to co-publish the journal Tumor Biology

HHS releases nation’s first comprehensive strategy to address existing and emerging health threats

Senate retirements focus Democrats on election prospects and health bill impact

Biovest International receives Orphan Drug Designation for its personalized lymphoma vaccine

UCLA: Metformin can be used to treat patients with diabetes and advanced heart failure

Epigenetic diagnosis and therapies, a new strategy for treating cancer

Opinions: Uganda anti-gay bill; Clinton's foreign policy speech; PEPFAR

Nightingale Informatix and CPA sign license and distribution agreement

Uninsured patients struggle to access health care as hospitals end programs

Additional birth weight decreases risk of developing tuberculosis later in life

CRF awards $1.75 million in 11 new grants to researchers to find a cure for cystinosis

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News